EvaLuation of treatment and course of hypErParatHyreoidism related to end stAge reNal disease – a mulTicenter analysis.
ELEPHANT-2 What is the effect of PTx compared to calcimimetics in the control of secondary HPT prior to kidney Tx?
Leading center: AMC; AF Engelsman
ELEPHANT-3 What is the effect of PTx compared to calcimimetics in the control of tertiary HPT post kidney Tx?
Leading center: EMC; TM van Ginhoven
ELEPHANT-4 What is the 30-day outcome and effectiveness of PTx in ESRD patients?
Leading center: UMCG; S Kruijff
ELEPHANT-5 Identifying predictors of spontaneous regression of hyperparathyroidism after kidney transplantation
Leading center: LUMC, A. Schepers
Een volledig overzicht van de verschillende ELEPHANT-trials vindt u in het linker menu